Form 4 Tracker
PTC THERAPEUTICS, INC.
PTCT

27 insider filings · Latest: Jun 26, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 18, 2026Feb 20 10:20 PMChristine Marie UtterSVP, CHIEF ACCOUNTING OFFICER
Sale
2,494$69.36$173.0K70,199(D)

View →

Feb 18, 2026Feb 20 10:20 PMPierre GravierCHIEF FINANCIAL OFFICER
Sale
2,992$69.36$207.5K87,318(D)

View →

Feb 18, 2026Feb 20 10:20 PMEric PauwelsCHIEF BUSINESS OFFICER
Sale
3,019$69.36$209.4K77,122(D)

View →

Feb 18, 2026Feb 20 10:20 PMMatthew B. KleinDirector, CHIEF EXECUTIVE OFFICER
Sale
7,371$69.36$511.3K387,082(D)

View →

Feb 18, 2026Feb 20 10:20 PMLee Scott GoldenEVP & CHIEF MEDICAL OFFICER
Sale
2,484$69.36$172.3K89,944(D)

View →

Feb 18, 2026Feb 20 10:20 PMNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER
Sale
3,121$69.36$216.5K6,726(I)

View →

Feb 18, 2026Feb 19 10:25 PMMark Elliott BouldingEXEC. VP AND CLO
Sale
3,081$69.36$213.7K108,231(D)

View →

Feb 17, 2026Feb 19 10:25 PMMark Elliott BouldingEXEC. VP AND CLO
Sale
2,813$69.29$194.9K111,312(D)

View →

Feb 19, 2026Feb 19 2:56 PMBoulding Mark Elliott
Proposed Sale
3,019$68.57$207.0K

View →

Feb 18, 2026Feb 18 10:12 PMPauwels Eric
Proposed Sale
3,019$69.36$209.4K

View →

Feb 18, 2026Feb 18 10:06 PMAlmstead Zheng Yang
Proposed Sale
65$69.36$4.5K

View →

Feb 18, 2026Feb 18 9:56 PMGravier Pierre
Proposed Sale
2,992$69.36$207.5K

View →

Feb 18, 2026Feb 18 9:56 PMAlmstead Neil Gregory
Proposed Sale
3,056$69.36$212.0K

View →

Feb 18, 2026Feb 18 9:55 PMUtter Christine Marie
Proposed Sale
2,494$69.36$173.0K

View →

Feb 18, 2026Feb 18 9:38 PMBoulding Mark Elliott
Proposed Sale
3,081$69.36$213.7K

View →

Feb 18, 2026Feb 18 9:25 PMGolden Lee Scott
Proposed Sale
2,484$69.36$172.3K

View →

Feb 18, 2026Feb 18 9:21 PMKlein Matthew B.
Proposed Sale
7,371$69.36$511.2K

View →

Feb 17, 2026Feb 17 5:51 PMBoulding Mark Elliott
Proposed Sale
2,813$69.14$194.5K

View →

Jan 9, 2026Jan 9 9:11 PMBoulding Mark Elliott
Proposed Sale
2,314$77.92$180.3K

View →

Jan 9, 2026Jan 9 9:09 PMPauwels Eric
Proposed Sale
2,746$77.89$213.9K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 26, 2026Jun 30 9:20 PMNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER
Option Exercise
8,130$38.1019,687(D)

View →

Jun 25, 2026Jun 26 9:20 PMNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER
Option Exercise
20,960$39.4236,150(D)

View →

Jun 24, 2026Jun 26 9:20 PMNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER
Option Exercise
5,323$38.1048,677(D)

View →

Jun 22, 2026Jun 24 9:20 PMNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER
Option Exercise
23,749$25.6923,751(D)

View →

Jun 17, 2026Jun 22 9:20 PMChristine Marie UtterSVP, CHIEF ACCOUNTING OFFICER
Option Exercise
19,686$25.6915,314(D)

View →

Jun 17, 2026Jun 22 9:20 PMMark Elliott BouldingEXEC. VP AND CLO
Option Exercise
10,522$46.5430,938(D)

View →

Jun 10, 2026Jun 12 9:30 PMEric PauwelsCHIEF BUSINESS OFFICER
Sale
17,566$18.010(D)

View →

May 15, 2026May 19 9:20 PMMark Elliott BouldingEXEC. VP AND CLO
Option Exercise
2,812$25.6919,689(D)

View →

May 8, 2026May 12 9:20 PMMark Elliott BouldingEXEC. VP AND CLO
Option Exercise
3,540$46.5441,460(D)

View →

Apr 6, 2026Apr 8 9:20 PMMark Elliott BouldingEXEC. VP AND CLO
Option Exercise
2,265$39.426,798(D)

View →

Mar 24, 2026Mar 26 11:41 PMJessica Caroline ChutterDirector
Grant/Award
6,371$64.542,896(D)

View →

Mar 10, 2026Mar 12 9:20 PMStephanie OkeyDirector
Option Exercise
15,167$33.630(D)

View →

Feb 17, 2026Feb 19 10:25 PMMark Elliott BouldingEXEC. VP AND CLO
Option Exercise
2,813$25.6922,501(D)

View →